Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.71% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.71% | -- | -- | -- | -- |
| Cost of Revenue | 29.75% | 24.86% | 29.83% | -18.34% | -36.21% |
| Gross Profit | -80.15% | 38.38% | 38.31% | 58.11% | 77.73% |
| SG&A Expenses | -47.07% | 1.47% | -9.83% | -7.52% | 35.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.18% | 18.29% | 18.57% | -15.57% | -16.74% |
| Operating Income | 8.12% | 27.19% | 30.22% | 45.15% | 46.99% |
| Income Before Tax | 4.74% | 33.34% | 36.40% | 52.10% | 51.20% |
| Income Tax Expenses | -330.30% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.72% | 33.34% | 34.00% | 52.10% | 51.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.72% | 33.34% | 34.00% | 52.10% | 51.05% |
| EBIT | 8.12% | 27.19% | 30.22% | 45.15% | 46.99% |
| EBITDA | 7.76% | 26.85% | 29.90% | 44.96% | 47.07% |
| EPS Basic | 23.22% | 54.02% | 49.06% | 62.86% | 62.62% |
| Normalized Basic EPS | 22.42% | 54.02% | 50.92% | 62.87% | 63.86% |
| EPS Diluted | 23.22% | 54.02% | 49.06% | 62.86% | 62.94% |
| Normalized Diluted EPS | 22.42% | 54.02% | 50.92% | 62.87% | 63.86% |
| Average Basic Shares Outstanding | 22.80% | 45.00% | 29.57% | 28.99% | 30.94% |
| Average Diluted Shares Outstanding | 22.80% | 45.00% | 29.57% | 28.99% | 30.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |